Day-to-day variation of urinary NGAL and rational for creatinine correction. Objectives: Clinical studies evaluating the new tubular biomarker urinary neutrophil gelatinase-associated lipocalin (U-NGAL) in urine increase and there is no consensus whether absolute U-NGAL concentrations or urinary NGAL/creatinine (U-NGAL/Cr) ratios should be used when chronic tubular dysfunction is studied. The aim was to study the biological variation of U-NGAL in healthy subjects and the rational for urinary Creatinine (U-Cr) correction in two different study samples.
Introduction
Neutrophil gelatinase-associated lipocalin (NGAL) [1] , also known as human neutrophil lipocalin (HNL) [2] and lipocalin-2, is a member of the lipocalin family of binding proteins and is in the circulation mainly produced by activated neutrophils. The main source of urinary NGAL (U-NGAL) is however tubular epithelial cells in the kidney [3] . NGAL is produced and secreted into the urine in response to ischemic kidney damage and is therefore a promising early indicator of tubulointerstitial damage [4, 5] . Recent clinical studies show that U-NGAL reflect acute renal damage early [6] [7] [8] [9] but may also signal chronic renal damage [10] [11] [12] [13] . When mild to moderate increases in U-NGAL concentrations are expected it is of essence to know whether U-NGAL should be measured as absolute values or as a ratio to urinary Creatinine (U-Cr). There is no consensus how to best estimate U-NGAL in this sense.
The aim of this study was to study the rational for U-Cr correction of U-NGAL using both young healthy subjects and a heterogeneous aged population and to study the biological dayto-day variation of U-NGAL in healthy subjects.
Patients and methods
To study the biological variation of U-NGAL and U-NGAL/Cr ratio and the associations between U-NGAL and U-Cr 13 young healthy male and female volunteers without medication (median age 29 years; interval 22-59 years) collected spot urine samples during ten successive days. The samples were collected in the morning (approximately 6-8 AM).
Additionally, to study the associations between U-NGAL and U-Cr in an older age-group a random subsample of 400 males, out of 839 males, collecting 24-hour urine during one day in the forth examination cycle of Uppsala Longitudinal Study of Adult Men (aged 77-78 years) [14] were examined. The samples were stored frozen at -70C until analysis. The study has been cleared by the Ethics Review Board for human studies and patients have signed informed consent. U-NGAL and U-NGAL/Cr ratio was skewed according to Shapiro-Wilks test (W<0.95) and was log-transformed. Both U-NGAL and U-NGAL/Cr ratio showed W >0.95 (Shapiro-Wilks test) after transformation, thus assumed to be normally distributed. We used linear regression and Pearson's correlation to study the linear associations between U-NGAL and U-NGAL/Cr ratio, respectively, and U-Cr in both study samples. To describe the biological variation of absolute U-NGAL and U-NGAL/Cr ratio in the healthy young subjects total CV (CV tot ) was calculated from the root mean square error using ANOVA. Analytical CV (CV ana ) for the NGAL method was calculated using multiple measurements of the same sample at different concentrations. CV ana for the U-NGAL/Cr ratio was estimated as the square root of the sum of the square of CV ana for the NGAL method and the square of CV ana for the U-Cr method. CV due to biological variation (CV biol ) was estimated by the formula CV tot 2 = CV biol 2 + CV ana 2 .
Calculations were performed with Stata 11.0 (College Station, TX). 5 
Results
Median and interquartile interval of U-NGAL and U-NGAL/Cr ratio in morning urine during 10 successive days in the healthy young subjects are presented in Table 1 
Discussion
The positive linear associations between U-NGAL and U-Cr seen in both young, healthy subjects and in the older male subsample somewhat support the theoretical basis for creatinine adjustment. However, this study points out some important issues to consider. Firstly, the calculated biological variation of U-NGAL/Cr ratio was 101% and thus considerably larger than the calculated biological variation of absolute U-NGAL which was only 27%. The theoretical basis for U-Cr adjustment is to compensate for variations in urine concentrations (assuming a steady U-Cr excretion rate), thus reducing the variation of the biomarker. This study indicate however the opposite; a higher biological day-to-day variation in U-NGAL/Cr ratio compared to absolute NGAL. The biological variation of the U-NGAL/Cr ratio is however at a similar level as in a recent study where the biological variation was estimated to 81 % for the U-NGAL/Cr ratio [15] . In the same study the biological variation of absolute U-NGAL was 84 % which is a considerably larger variation than in this study.
Secondly, it is important to bear in mind that adjustment with urinary creatinine may actually cause "overadjustment", as seen in the negative correlations between the U-NGAL/Cr ratio and creatinine in this study. An overadjustment of creatinine may potentially impact associations and interpretation of results in clinical studies. Given the relatively week correlation between U-NGAL and U-Cr and the risk of overadjustment by creatinine as discussed above it is reasonable to suggest that laboratories should report both absolute U-NGAL and U-NGAL/Cr ratios for the estimation of chronic tubular dysfunction.
The study included apparently healthy subjects and participants from a community cohort who possible are healthier than the general population and the results of the study are not necessarily applicable to patients with specific diagnosis. Excretion of creatinine may vary with changes in glomerular filtration rate, thus the results may not be extrapolated to patients with acute kidney diseases [16] . To further evaluate the clinical importance and prognostic utility of U-NGAL versus U-NGAL/Cr ratio large prospective cohort studies are needed. In conclusion, this study provide some support for the use of U-NGAL/Cr ratio but the rather large biological variation and the risk of overadjustment must be taken into account when planning and interpreting a clinical study intended to study chronic tubular dysfunction. 
